Kevin Koch Ph.D.
Net Worth
Last updated:
What is Kevin Koch Ph.D. net worth?
The estimated net worth of Dr. Kevin Koch Ph.D. is at least $1,638,585 as of 2 May 2024. He owns shares worth $190,458 as insider, has earned $88,127 from insider trading and has received compensation worth at least $1,360,000 in Edgewise Therapeutics, Inc..
What is the salary of Kevin Koch Ph.D.?
Dr. Kevin Koch Ph.D. salary is $680,000 per year as Pres, Chief Executive Officer & Director in Edgewise Therapeutics, Inc..
How old is Kevin Koch Ph.D.?
Dr. Kevin Koch Ph.D. is 65 years old, born in 1960.
What stocks does Kevin Koch Ph.D. currently own?
As insider, Dr. Kevin Koch Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | Pres, Chief Executive Officer & Director | 14,478 | $13.16 | $190,458 |
What does Edgewise Therapeutics, Inc. do?
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.
Kevin Koch Ph.D. insider trading
Edgewise Therapeutics, Inc.
Dr. Kevin Koch Ph.D. has made 2 insider trades between 2023-2024, according to the Form 4 filled with the SEC. Most recently he sold 3,152 units of EWTX stock worth $59,604 on 2 May 2024.
The largest trade he's ever made was exercising 10,417 units of EWTX stock on 1 May 2024. As of 2 May 2024 he still owns at least 14,478 units of EWTX stock.
Edgewise Therapeutics key executives
Edgewise Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Alan J. Russell Ph.D. (55) Co-Founder, Chief Scientific Officer & Director
- Dr. Kevin Koch Ph.D. (65) Pres, Chief Executive Officer & Director
- Mr. R. Michael Carruthers (67) Chief Financial Officer